US-UK pharma deal isn’t enough to get AstraZeneca investing in Britain again – POLITICO
“It will probably not be sufficient for many of these fully innovative products,” he said. “We need to remember the risk, not only the cost, but the risk involved in the development.” Ministers have ramped up their lobbying efforts — including a visit by health minister Seema Malhotra to AstraZeneca’s Cambridge site last week – […]
Continue Reading